全能2C类状态保护了小鼠胚胎干细胞的基因组稳定性
Zeling Du1,2,3, Meiqi Lin1,2,3, Qiaohua Li1,2,3
1State Key Laboratory of Primate Biomedical Research, Kunming University of Science and Technology, Kunming, China.
Journal of cellular physiology
|June 11, 2024
概括
鼠标胚胎干细胞 (mESC) 通过过渡到类似于双细胞 (2C) 的状态来保持基因组稳定性. 消除这些2C类细胞 (2CLCs) 损害了DNA修复,导致基因组不稳定性和细胞增殖减少.
科学领域:
- 干细胞生物学 干细胞生物学
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 小鼠胚胎干细胞 (mESCs) 具有显著的基因组稳定性.
- 一个罕见的2C类细胞 (2CLCs) 亚群暂时类似于早期胚胎芽细胞体.
- 2CLCs在维护mESC基因组完整性的作用尚未完全理解.
研究的目的:
- 研究2CLCs在mESC培养中的生物学意义.
- 确定消除2CLCs对mESC基因组稳定性和自我更新的影响.
- 探索p53在对2CLC枯竭的反应中的作用.
主要方法:
- 产生一种可诱导的报告系统,用于特定的2CLC消除.
- 在mESCs中评估DNA损伤,突变和重新排列.
- 对亡和扩散率的分析.
- 在没有2CLC的情况下评估mESC行为,有或没有p53缺乏.
主要成果:
- 消除2CLC导致了显著的DNA损伤积累,基因组突变和重组.
- 在去除2CLC时,mESC亡增加,扩散减少.
- 在2CLC贫乏培养中,p53缺乏加剧了DNA损伤和基因组不稳定性.
- 这种类似2C的状态对于维持mESC基因组稳定性至关重要.
结论:
- 过渡到2C类状态是mESC基因组稳定性的关键内在机制.
- 2CLCs对于防止DNA损伤和确保mESCs长期自我更新至关重要.
- 了解2CLC对基因组稳定性的贡献,可以了解干细胞的维护.
相关概念视频
Maintenance of the ES Cell State
2.2K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.2K
Zygotic Development And Stem Cell Formation
5.1K
The development of all multicellular organisms starts with the fusion of haploid cells called sperm and egg to form a diploid zygote. A zygote is a totipotent cell that can develop into a complete organism. The zygote undergoes cell division or cleavage to form an 8-cell mass. Until this stage, the cells are spherical, loosely attached, and remain totipotent. Totipotent cells are capable of developing both the embryonic and the extraembryonic tissues. However, as they continue to divide, they...
5.1K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Embryonic Stem Cells
3.5K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.5K
Source And Potency Of Stem Cells
4.8K
Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
4.8K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


